Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-09 6:05 pm Sale | 2025-12-09 | 13D | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 0 0.000% | -2,149,880![]() (Position Closed) | Filing History |
| 2025-12-09 5:31 pm Sale | 2025-12-09 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -4,288,949![]() (Position Closed) | Filing History |
| 2025-12-05 6:18 pm Sale | 2025-12-04 | 13D | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,149,880 9.700% | -1,099,446![]() (-33.84%) | Filing History |
| 2025-11-28 3:25 pm Purchase | 2025-11-25 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 4,288,949 19.400% | 3,159,892![]() (+279.87%) | Filing History |
| 2025-11-10 12:32 pm Unchanged | 2025-11-10 | 13D | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 3,249,326 15.600% | 0 (Unchanged) | Filing History |
| 2025-08-14 1:04 pm Purchase | 2025-08-12 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 1,129,057 5.400% | 1,129,057![]() (New Position) | Filing History |
| 2025-08-05 11:51 am Sale | 2025-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM | FRANKLIN RESOURCES INC BEN | 0 0.000% | -1,760,056![]() (Position Closed) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 414,485 2.000% | -1,076,224![]() (-72.20%) | Filing History |
| 2025-05-20 08:27 am Purchase | 2025-05-19 | 13D | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 3,249,326 15.600% | 367,009![]() (+12.73%) | Filing History |
| 2025-05-15 4:34 pm Sale | 2025-03-31 | 13G | Adverum Biotechnologies, Inc. ADVM | TCG Crossover GP II, LLC | 1,871,482 8.900% | -204,875![]() (-9.87%) | Filing History |
| 2025-05-06 09:15 am Purchase | 2025-03-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,882,317 13.800% | 508,913![]() (+21.44%) | Filing History |
| 2025-02-14 6:10 pm Unchanged | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-13 3:25 pm Purchase | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,373,404 11.400% | 167,058![]() (+7.57%) | Filing History |
| 2024-12-17 5:11 pm Purchase | 2024-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Rush Ryan Bradford | 1,050,000 5.100% | 1,050,000![]() (New Position) | Filing History |
| 2024-11-14 6:57 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings, L.P. | 218,895 1.100% | 218,895![]() (New Position) | Filing History |
| 2024-11-14 6:40 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Logos Global Management LP | 416,666 2.000% | 416,666![]() (New Position) | Filing History |
| 2024-11-14 4:05 pm Unchanged | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 234,718 1.128% | 234,718![]() (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 1,490,709 7.200% | 0 (Unchanged) | Filing History |
| 2024-11-06 5:49 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 78,862 0.400% | 78,862![]() (New Position) | Filing History |

